Company intelligence / Profile preview
Zywie
United Stateszywiebio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Therapeutics arm has Ambroxol in Phase 2 trials for Parkinson’s Disease Dementia, focusing on improving lysosomal function. Medtech arm has commercialized wearable ECG biosensors and cloud analytics for remote cardiac monitoring.
- Therapeutic areas
- Rare DiseasesNeurologyMetabolic DisordersCardiovascular
- Modalities
- Small moleculeDevice
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
MedAxiom partnership to expand cardiovascular care solutions (for medtech/cardiac division)Lovell Government Services partnership for federal contracts (for medtech/cardiac division)
Beyond the preview
Go deeper on Zywie.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zywie.